Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trialHilko Ardon, Steven De Vleeschouwer, Stefaan W. Van Gool et al.|Cancer Immunology Immunotherapy|2012Cited by 162
Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot studyHilko Ardon, Steven De Vleeschouwer, Stefaan Van Gool et al.|Journal of Neuro-Oncology|2010Cited by 146
Adjuvant dendritic cell‐based tumour vaccination for children with malignant brain tumoursHilko Ardon, Stefaan W. Van Gool, Steven De Vleeschouwer et al.|Pediatric Blood & Cancer|2009Cited by 145
DENDRITIC CELL VACCINATION IN PATIENTS WITH MALIGNANT GLIOMASSteven De Vleeschouwer, Michael Sabel, Marion Rapp et al.|Neurosurgery|2006Cited by 67
Living with a high-grade glioma: A qualitative study of patients' experiences and care needsWendy Sterckx, Bernadette Dierckx de Casterlé, Annemarie Coolbrandt et al.|European Journal of Oncology Nursing|2015Cited by 61